期刊文献+

三阴乳腺癌的特征及治疗现状 被引量:21

Characters and Therapy of Triple-Negative Breast Cancer
原文传递
导出
摘要 目的探讨三阴乳腺癌的特征及治疗现状。方法以"三阴乳腺癌"、"特征"、"治疗"为关键词进行检索并筛选阅读相关文献进行综述。结果三阴乳腺癌是乳腺癌的一种特殊亚型,肿瘤细胞缺乏雌激素受体、孕激素受体及人类上皮细胞生长因子受体2,其临床特点及预后不同于其他类型的乳腺癌,发病年龄小、无病生存率及总生存率较低。目前尚缺乏针对三阴乳腺癌的治疗指南,多参照非三阴乳腺癌的治疗,主要包括外科手术治疗且保乳手术后推荐常规行放射治疗、全身化疗,靶向治疗正处于临床研究阶段。结论三阴乳腺癌是乳腺癌表现异质性特征之一,其间还存在着许多的不同点。为了改善三阴乳腺癌的预后,我们期待在将来的工作中发现更多对于三阴乳腺癌有意义的检测指标,便于制定出三阴乳腺癌个体化治疗方案。 Objective To explore the characters and therapy of the triple-negative breast cancer(TNBC).Methods The pertinent literatures with key words"triple-negative breast cancer","diagnosis",and"therapy"were retrieved and reviewed.Results TNBC was a subtype of breast cancer characterized by negative expressions of estrogen receptor(ER),progesterone receptor(PR),and human epidermal growth factor receptor-2(HER-2).The clinicopathologic feature and prognosis of TNBC were distinct from other breast cancer.The age of onset was younger,disease free survival and total survival rate were lower in the patients with TNBC.At present,the therapy guideline was lack of TNBC,which referred to the non-TNBC,including local surgery,systemic chemotherapy,and the target therapy was at the clinical trial stage.Conclusions TNBC is one of heterogeneity characteristics for the breast cancer,which has extra much difference.For improving the TNBC prognosis,we hope that more and more significant markers to TNBC in the future are found,which are useful to make individuation treatment.
出处 《中国普外基础与临床杂志》 CAS 2012年第9期1024-1027,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 三阴乳腺癌 诊断 治疗 Triple-negative breast cancer Diagnosis Therapy
  • 相关文献

参考文献33

  • 1Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J]. Cancer, 2007, 109(9):1721-1728.
  • 2Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109(1): 25-32.
  • 3Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer [J]. J Natl Cancer Inst, 2003, 95(19): 1482-1485.
  • 4袁中玉,王树森,高岩,苏争艳,罗文标,管忠震.305例三阴乳腺癌患者的临床特征及预后因素分析[J].癌症,2008,27(6):561-565. 被引量:161
  • 5Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer[J]. J Clin Oncol, 2006, 24(36):5652-5657.
  • 6Perou CM, S?rlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797):747-752.
  • 7Kim MJ, Ro JY, Ahn SH, et al. Clinicopathologic significance of the basal-like subtype of breast cancer:a comparison with hormone receptor and Her2/neu-overexpressing phenotypes[J]. Hum Pathol, 2006, 37(9):1217-1226.
  • 8Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16):5367-5374.
  • 9Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC)[J]. J Clin Oncol, 2006, 24(18S):508.
  • 10Mullan PB, Quinn JE, Harkin DP. The role of BRCA1 in transcriptional regulation and cell cycle control[J]. Oncogene, 2006, 25(43):5854-5863.

二级参考文献19

  • 1Perou C M, Sorlie T, Eisen M-B, et al. Molecular portraits of human breast tumors [J]. Nature, 2000,406(6797) :747-752.
  • 2van't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer [J ]. Nature, 2002,415(6871 ) : 530-536.
  • 3Sotiriou C, Neo S Y, McShane L M, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study [J]. Proc Natl Acad Sci USA, 2003,100(18) : 10393-10398.
  • 4Rakha E A, El-Sayed M E, Green A R, et al. Prognostic markers in triple-negative breast cancer [J]. Cancer, 2007, 109( 1 ) : 25-32.
  • 5Jones C, Nonni A V, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation [ J ]. Br J Cancer, 2001,85 ( 3 ) : 422-427.
  • 6Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004, 10 (16) :5367-5374.
  • 7Banerjee S, Reis-Filho J S, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J]. J Clin Pathol, 2006,59(7):729-735.
  • 8Carey L A, Dees E C, Sawyer L, et al. The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes [J]. Clin Cancer Res, 2007,13(8) :2329-2334.
  • 9Chu K C, Lamar C A, Freeman H P. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment [J]. Cancer, 2003, 97( 11 ) : 2853-2860.
  • 10Cunningham J E, Butler W M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis [ J ]. Breast Cancer Res Treat, 2004,88 (2) : 161-176.

共引文献160

同被引文献229

引证文献21

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部